Diagnos Laboratorium Utama Tbk. vs Royalindo Investa Wijaya Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Royalindo Investa Wijaya Tbk. trades at Rp169 (market cap 757.25B, 15.71M 24h volume). The key difference: Royalindo Investa Wijaya Tbk. is far larger — about 2.4× Diagnos Laboratorium Utama Tbk.'s market cap, and Royalindo Investa Wijaya Tbk. is more actively traded (15.71M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | INDO | |
|---|---|---|
Market Cap | 310.75B | 757.25B |
Volume | 963.6K | 15.71M |
Lot | 9.64K | 157.07K |
Turnover | 217.67M | 2.65B |
Average Price | 225.89 | 168.92 |
Value | 217.67M | 2.65B |
Indicative Equilibrium Price | 226 | 169 |
Indicative Equilibrium Volume | 1K | 23 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Royalindo Investa Wijaya Tbk (the Company) was established based on Notarial Deed No. 19 dated July 6, 2005 of Tse Min Suhardi, S.H., a public notary in Jakarta. The Company started its commercial operations in July 6, 2005.
Read more on INDO →